Sale of 5,506 shares at $112.42 per share.
Reporting Person Mainolfi Nello · Officer Title Chief Executive Officer · Transaction Code S
Traded Oct 1, 2026 · Disclosed Oct 1, 2026
Source: SEC Form 4 · 0001193125-26-410839 · filed 2026-10-01 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Kymera Therapeutics, Inc. (KYMR)." Disclosed 2026-10-01. https://desqlong.com/cards/0001193125-26-410839-3 (retrieved 2026-10-02).